HIV Resistance Current Events | HIV Resistance News
|
| Page
1 of
58 |
1150 Results |
|
|
|
Sort By:
Page Views | Date |
HIV drug resistance is increasing in the UK
The prevalence of transmitted HIV drug resistance in the United Kingdom is increasing, according to a study in this week's BMJ. This finding emphasises the urgent need for new approaches to encourage safer sexual behaviour. A total of 69 patients infected with HIV between June 1994 and August 2000 were evaluated for resistance within 18 months of... view more... (2001-05-02)
Concern over uncontrolled use of HIV drugs
Uncontrolled use of antiretroviral drugs in developing countries could accelerate HIV resistance, warn researchers in this week’s BMJ. view more (2003-06-18)
Fat on chest and upper back increases risk of insulin resistance
Upper trunk fat -- deposits of fat on the chest and back -- is associated with an increased risk of insulin resistance, a condition that is a precursor of type 2 diabetes, according to a study led by researchers at the San Francisco VA Medical Center (SFVAMC). view more (2007-08-20)
HIV drug resistance risk in mothers reduced by combination of common drugs
New research from the University of Alabama at Birmingham (UAB) shows that adding a single dose of two common anti-HIV drugs can prevent HIV-positive pregnant women from developing resistance to an entire class of drugs, potentially improving future treatment options. view more (2007-11-12)
Europe becoming complacent over HIV prevention
Rising levels of gonorrhoea and syphilis across western Europe since 1995 imply that complacency over HIV prevention efforts may have set in among individuals and some governments, argue researchers in this week's BMJ. Angus Nicoll and Francoise Hamers examined national trends in diagnosed HIV infections, gonorrhoea, and infectious syphilis from... view more... (2002-05-28)
U of M researchers discover new method to combat HIV
Researchers at the University of Minnesota's Center for Drug Design have developed a new method to combat HIV/AIDS, potentially replacing the traditional cocktail drug approach. view more (2007-07-24)
Ultra deep sequencing identifies HIV drug resistance at early stage
Rare, previously undetectable drug-resistant forms of HIV have been identified by Yale School of Medicine researcher Michael Kozal, M.D., using an innovative genome sequencing technology that quickly detects rare viral mutations. view more (2007-06-18)
Chronic HIV-1 infection frequently fails to protect against superinfection
Natural HIV-1 infection does not always elicit a protective immune response, according to a new study published November 16 in PLoS Pathogens. view more (2007-11-16)
Malaria treatment efficacy compromised in certain HIV-positive patients
A weakened immune response resulting from HIV infection can lead to trouble when it comes to treating malaria. view more (2006-09-08)
MU Researcher Refining Synthetic Molecules to Prevent HIV Resistance
Evolving HIV viral strains and the adverse side effects associated with long-term exposure to current treatments propel scientists to continue exploring alternative HIV treatments. view more (2008-12-17)
Drug to Block Mother-to-Child HIV Transmission Induces Resistance
The incidence of drug resistance associated with single-dose nevirapine, a drug used to prevent mother-to-child transmission of HIV-1, may be substantially higher than previously thought and of particular risk for those infected with HIV-1 subtype C, according to three new studies published in the July 1 issue of The Journal of Infectious... view more... (2005-06-02)
Infertility clinics are biased against patients with HIV
Infertility clinics are biased against patients infected with HIV, finds a study in this week's BMJ. view more (2001-11-28)
Transmission of drug-resistant HIV-1
Drug-resistant forms of HIV can be spread between individuals who have not received anti-retroviral treatment. view more (2009-03-30)
Treatment outcomes of patients with HIV and tuberculosis
In a retrospective study of 700 patients with culture-positive tuberculosis (TB), relapse rates were found to be significantly higher in HIV-infected patients compared to HIV-uninfected patients following a rifamycin-based regimen. view more (2007-06-01)
New Stanford list of HIV mutations vital to tracking AIDS epidemic
In a collaborative study with the World Health Organization and seven other laboratories, researchers at the Stanford University School of Medicine have compiled a list of 93 common mutations of the AIDS virus associated with drug resistance that will be used to track future resistance trends throughout the world. view more (2009-03-06)
The Role Of Sexually Transmitted Diseases, Malaria, And Tuberculosis On The Hiv-1/Aids Epidemic In Africa (p 2177)
The effect of HIV-1 on other infectious diseases in Africa is an increasing public health concern. In a review in this week's issue of THE LANCET, Elizabeth Corbett from the London School of Hygiene and Tropical Medicine, UK, and the Harare Biomedical Research and Training Institute, Zimbabwe, and colleagues describe the role that three major... view more... (2002-06-19)
Viral 'fitness' explains different resistance patterns to aids drugs
Some HIV medications lead to the development of drug-resistant HIV when patients take as few as two percent of their medications. view more (2006-01-11)
MU scientists 'see' how HIV matures into an infection
After improving the sensitivity of nuclear magnetic resonance (NMR), researchers at the University of Missouri actually watched the HIV-1 protease mature from an inactive form into an active infection. This process has never been directly visualized before. The findings appear today in the journal Nature. view more (2008-10-02)
New drug candidate against HIV developed in Sweden
As a part of a research collaboration, scientists at the Sahlgrenska Academy at Göteborg University, Sweden, have developed a new drug candidate against HIV-infection. view more (2005-06-30)
Prolonged nevirapine in breast-fed babies prevents HIV infection but leads to drug-resistant HIV
Babies born to HIV-positive mothers and given the antiretroviral drug nevirapine through the first six weeks of life to prevent infection via breast-feeding are at high risk for developing drug-resistant HIV if they get infected anyway, a team of researchers report. view more (2009-01-06)
|
|
| Page
1 of
58 |
1150 Results |
|
|
|
Sort By:
Page Views | Date |
|
